Aktive Wirkstoffe | Info Patient

(1R,2S,5S)-N-((1S)-1-Cyano-2-((3S)-2-oxopyrrolidin-3-yl)ethyl)-3-((2S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido) butanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide, ritonavir
5-aminolevulinic acid hydrochloride
6-mercaptopurine monohydrate
A/Cambodia/e0826360/2020 (H3N2)-like strain (A/Tasmania/503/2020, wild type)
A/Indonesia/05/2005 (H5N1) like strain used (PR8-IBCDC-RG2)
A Turkey 14/98 ≥ 6 PD50*
A/Victoria/2570/2019 (H1N1)pdm09 like strain (A/Victoria/1/2020, MEDI 340505) A/Cambodia/e0826360/2020 (H3N2) - like strain (A/Tasmania/503/2020, MEDI 339018) B/Washington/02/2019 like strain (B/Washington/02/2019, MEDI 323797) B/Phuket/3073/2013 like
A/Victoria/2570/2019 (H1N1)pdm09 - like strain (A/Victoria/2570/2019 IVR‐215) A/Cambodia/e0826360/2020 (H3N2) - like strain (A/Cambodia/e0826360/2020 IVR‐224) B/Washington/02/2019 – like strain (B/Victoria/705/2018 BVR‐11) B/Phuket/3073/2013 – like strain
A/Wisconsin/588/2019 (H1N1)pdm09-like strain (A/Washington/19/2020, wild type)
A22 Iraq ≥ 6 PD50*
A24 Cruzeiro ≥ 6 PD50*
abacavir
abacavir (as sulfate), lamivudine, zidovudine
abacavir, lamivudine
Abatacept
abemaciclib
abiraterone acetate
Abrocitinib
Acalabrutinib
acetylsalicylic acid, clopidogrel hydrogen sulfate
aclidinium bromide
aclidinium bromide, formoterol fumarate dihydrate
adalimumab
adefovir dipivoxil
adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein (Ad26.COV2-S)
afamelanotide
afatinib
aflibercept
afoxolaner
afoxolaner, milbemycin oxime
agalsidase alfa
agalsidase beta
Agomelatine
Albiglutide
albutrepenonacog alfa
alectinib hydrochloride
alemtuzumab
alendronic acid, colecalciferol
alglucosidase alfa
alipogene tiparvovec
Alirocumab
aliskiren
aliskiren, amlodipine
aliskiren, amlodipine, hydrochlorothiazide
aliskiren, hydrochlorothiazide
alitretinoin
Allogeneic T cells genetically modified with a retroviral vector encoding for a truncated form of the human low affinity nerve growth factor receptor (ΔLNGFR) and the herpes simplex I virus thymidine kinase (HSV-TK Mut2)
allopurinol, lesinurad
alogliptin
alogliptin benzoate, metformin hydrochloride
alogliptin, pioglitazone
Alpelisib
ambrisentan
amifampridine
amivantamab
Amlodipine besilate, valsartan
amlodipine, valsartan
amlodipine, valsartan, hydrochlorothiazide
amprenavir
Anagrelide
Anagrelide hydrochloride
anakinra
andexanet alfa
Angiotensin II acetate
anidulafungin
anifrolumab
Antithrombin alfa
apalutamide
Apixaban
apremilast
Aprepitant
aripiprazole
Arsenic trioxide
artesunate
asenapine (as maleate)
asfotase alfa
Asia 1 Shamir ≥ 6 PD50*
asparaginase
Ataluren
atazanavir (as sulfate)
atezolizumab
atidarsagene autotemcel
atosiban (as acetate)
attenuated feline panleucopenia virus (PLI IV)
attenuated feline rhinotracheitis herpesvirus (FHV F2 strain), inactivated feline calicivirosis antigens (FCV 431 and G1 strains)
attenuated feline rhinotracheitis herpesvirus (FHV F2 strain), inactivated feline calicivirosis antigens (FCV 431 and G1 strains), attenuated Chlamydophila felis (905 strain)
attenuated feline rhinotracheitis herpesvirus (FHV F2 strain), inactivated feline calicivirosis antigens (FCV 431 and G1 strains), attenuated Chlamydophila felis (905 strain), attenuated feline panleucopenia virus (PLI IV)
attenuated feline rhinotracheitis herpesvirus (FHV F2 strain), inactivated feline calicivirosis antigens (FCV 431 and G1 strains), attenuated feline panleucopenia virus (PLI IV), FeLV recombinant canarypox virus (vCP97)
attenuated feline rhinotracheitis herpesvirus (FHV F2 strain), inactivated feline calicivirosis antigens (FCV 431 and G1 strains), attenuated feline panleucopenia virus (PLI IV), FeLV recombinant canarypox virus (vCP97), attenuated Chlamydophila felis
attenuated live rabies vaccine virus, strain SPBN GASGAS
Autologous CD34+ cell enriched population that contains hematopoietic stem cells transduced with lentiglobin BB305 lentiviral vector encoding the beta-A-T87Q-globin gene
autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human adenosine deaminase (ADA) cDNA sequence from human haematopoietic stem/progenitor (CD34+) cells
autologous cultured chondrocytes
autologous peripheral-blood mononuclear cells including a minimum of 50 million autologous CD54+ cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor
Autologous peripheral blood T cells CD4 and CD8 selected and CD3 and CD28 activated transduced with retroviral vector expressing anti-CD19 CD28/CD3-zeta chimeric antigen receptor and cultured
Avacopan
avanafil
avapritinib
avatrombopag maleate
avelumab